¿Û¿Û´«Ã½

A smart shift means this beleaguered outsourcer is now a buy

Shares have further to run as this group’s shift to defence and the US plays out

This pharma giant has been oversold

Fears about the erosion of future revenues as patents expire have weighed on Merck’s valuation

Bag a 14% yield with this trust

Investors are being paid to wait for a recovery in sentiment towards this energy efficiency trust

This cash-rich gaming giant is more profitable than it looks

Conservative revenue recognition policies mean it is bringing in more cash than its bottom line suggests

A building company sitting on firm foundations

Two years of tough trading shouldn’t detract from the strong long-term fundamentals

Ignore the profit warning – this defence giant is ready to fire

A short-term slowdown in orders does not detract from the investment case

This smart manufacturer is insulated from the trade war

It already has a globalised footprint and huge market share – moves that could soon pay off

A top-performing global trust that doesn’t rely on America

This fund is comfortably beating the global stock market index without relying on one single country, setting it apart from its peers

This bargain oil stock is building for the future

The African producer is in a temporary fallow period, but the share price has fallen too far

This ad agency could be the next ‘quality stock’

The group is outshining rivals, with industry-leading margins and a model fit for tougher times